期刊文献+

6城市138家医院1999年~2001年抗结核药物的用药调查及趋势分析 被引量:7

Investigation and Analysis of Antituberculotics Used in 138 Hospitals of Six Cities During the 1999~2001 Period and Trend Analysis
下载PDF
导出
摘要 目的 :掌握6城市医院抗结核药物的用药现状及发展趋势。方法 :调查、分析长江流域6城市138家医院1999年~2001年抗结核药物的用药金额、生产企业销售金额、临床应用情况。结果 :抗结核药物的用药金额1999年、2000年、2001年分别为6227520元、7204738元、7537601元 ,呈逐年上升趋势 ;医院平均每年每床位应用抗结核药物的金额为282元。结论 :抗结核药物的品种相对比较少、价格便宜 ,但在医院中占有重要的地位 。 OBJECTIVE:To analyze the present situation and trend of the application of antituberculotics in hospitals of 6 cities METHODS:The antituberculotics used in 138 hospitals of 6 cities during the 1999~2001 period were analysed in respect to the cost,sales volume of pharmaceutical enterprises and situation of clinical application RESULTS:The costs of consumption of antituberculotics were 6 227 520,7 204 738 and 7 537 601 yuan in 1999,2000 and 2001 respectively with a rising trend year by year The average annual cost of antituberculotics was 282 yuan per sickbed CONCLUSION:The antituberculotics are fewer in kind and inexpensive in price but they occupy an important place in a hospital and their consumption is unceasingly increasing
出处 《中国医院用药评价与分析》 2002年第3期149-151,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 抗结核药 用药金额 销售金额 临床应用 现状 发展趋势 合理用药 antituberculotic survey of drug use trend analysis6
  • 相关文献

参考文献6

  • 1Brien RJ,Vernon AA.New tuberculosis drug development how can we do better[J] .Am J Respir Crit Care Med, 1998,157(6): 1 705.
  • 2Josefson D.FDA appoves tuberculosis drug(New)[J].BMJ, 1998,317: 11.
  • 3McGregor MM,Olliaro P,Wolmarans L,et al.Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis[J] .Am J Respir Crit Care Med, 1996,154(5): 1 462.
  • 4Tam CM,Chan SL,Lam CW,et al.Rifapentine and lsoniazid in the continuation phase of treating pulmonary tuberculosis[J] .Am J Respir Crit Care Med, 1998, 157(6): 1 726.
  • 5陆宇,朱莉贞,段连山.氟喹诺酮类药物的抗结核作用[J].中华结核和呼吸杂志,1999,22(11):693-696. 被引量:132
  • 6Deol P,Khuller GK,Joshi K.Therapentio efficacies of isoniazid and rifampin encapsulated in lung- specific stealth liposomes against mycoba cterium tuberculosis infection induced in mice [J] . Antimicrob Agents Chemother, 1997,41(6) :1 211.

二级参考文献5

  • 1田治明,国外医药.抗生素分册,1995年,16卷,60页
  • 2张致平,中国抗生素杂志,1995年,20卷,79页
  • 3Ji B,Tubercle,1991年,72期,181页
  • 4Ji B,Antimicrob Agents Chemother,1998年,42期,2066页
  • 5Ji B,Antimicrob Agents Chemother,1995年,39期,1341页

共引文献131

同被引文献30

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部